NIH-funded research NIH-funded research

Developing vaccines for viruses transmitted by ticks and mosquitoes

Official title: Project 1: Vaccine Design Neurotropic Flaviviruses

Funded at Washington University · NIH-10863002 · Data updated 2026-11-12

This study is working on new vaccines to help protect people from serious diseases caused by viruses spread by ticks and mosquitoes, like West Nile and Zika, so that everyone can have better defense against these illnesses.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startAugust 12, 2024
Project endJuly 31, 2027
Funding year2024
Award (this year)$4,728,047
NIH project number1U19AI181960-01
Project IDNIH-10863002 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk of infection from neurotropic flaviviruses, particularly those living in areas where these viruses are prevalent.

Less likely to help

Patients who are not at risk of exposure to tick- or mosquito-borne viruses may not benefit from this research.

What this research studies

This research focuses on creating vaccines to protect against neurotropic flaviviruses, which are transmitted by ticks and mosquitoes and can cause severe neurological diseases. The team will use innovative immunogen design strategies to develop and optimize vaccine candidates, specifically targeting the envelope glycoprotein of these viruses. By employing a modular approach, they aim to create vaccines that can be adapted for various emerging viral threats. Patients may benefit from enhanced protection against diseases like West Nile virus and Zika virus.

Why it matters

Potential benefit: If successful, this research could lead to effective vaccines that significantly reduce the incidence of severe viral infections transmitted by arthropods.

How similar studies have gone: Previous research has shown promise in developing vaccines for similar viral infections, indicating that this approach has potential for success.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Schmidt, Aaron Gregory — Washington University
  • Study coordinator: Schmidt, Aaron Gregory

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.